India · Delayed Price · Currency is INR Remus Pharmaceuticals Statistics
Total Valuation
NSE:REMUS has a market cap or net worth of INR 8.31 billion. The enterprise value is 8.40 billion.
| Market Cap | 8.31B |
| Enterprise Value | 8.40B |
Important Dates
The last earnings date was Wednesday, May 20, 2026.
| Earnings Date | May 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:REMUS has 11.66 million shares outstanding. The number of shares has decreased by -19.90% in one year.
| Current Share Class | 11.66M |
| Shares Outstanding | 11.66M |
| Shares Change (YoY) | -19.90% |
| Shares Change (QoQ) | -2.27% |
| Owned by Insiders (%) | 69.50% |
| Owned by Institutions (%) | n/a |
| Float | 3.45M |
Valuation Ratios
The trailing PE ratio is 18.18.
| PE Ratio | 18.18 |
| Forward PE | n/a |
| PS Ratio | 0.97 |
| PB Ratio | 2.14 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | 231.39 |
| P/OCF Ratio | 45.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.81, with an EV/FCF ratio of 233.87.
| EV / Earnings | 22.70 |
| EV / Sales | 0.98 |
| EV / EBITDA | 14.81 |
| EV / EBIT | 15.57 |
| EV / FCF | 233.87 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.98 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | 7.54 |
| Interest Coverage | 36.69 |
Financial Efficiency
Return on equity (ROE) is 13.78% and return on invested capital (ROIC) is 11.70%.
| Return on Equity (ROE) | 13.78% |
| Return on Assets (ROA) | 6.67% |
| Return on Invested Capital (ROIC) | 11.70% |
| Return on Capital Employed (ROCE) | 12.56% |
| Weighted Average Cost of Capital (WACC) | 5.60% |
| Revenue Per Employee | 125.54M |
| Profits Per Employee | 5.44M |
| Employee Count | 68 |
| Asset Turnover | 1.69 |
| Inventory Turnover | 12.01 |
Taxes
In the past 12 months, NSE:REMUS has paid 129.90 million in taxes.
| Income Tax | 129.90M |
| Effective Tax Rate | 21.96% |
Stock Price Statistics
The stock price has decreased by -28.00% in the last 52 weeks. The beta is 0.25, so NSE:REMUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -28.00% |
| 50-Day Moving Average | 689.99 |
| 200-Day Moving Average | 732.04 |
| Relative Strength Index (RSI) | 45.85 |
| Average Volume (20 Days) | 14,830 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:REMUS had revenue of INR 8.54 billion and earned 369.90 million in profits. Earnings per share was 39.19.
| Revenue | 8.54B |
| Gross Profit | 1.11B |
| Operating Income | 539.30M |
| Pretax Income | 591.60M |
| Net Income | 369.90M |
| EBITDA | 566.90M |
| EBIT | 539.30M |
| Earnings Per Share (EPS) | 39.19 |
Balance Sheet
The company has 549.10 million in cash and 270.70 million in debt, with a net cash position of 278.40 million or 23.88 per share.
| Cash & Cash Equivalents | 549.10M |
| Total Debt | 270.70M |
| Net Cash | 278.40M |
| Net Cash Per Share | 23.88 |
| Equity (Book Value) | 3.88B |
| Book Value Per Share | 375.66 |
| Working Capital | 1.46B |
Cash Flow
In the last 12 months, operating cash flow was 181.60 million and capital expenditures -145.70 million, giving a free cash flow of 35.90 million.
| Operating Cash Flow | 181.60M |
| Capital Expenditures | -145.70M |
| Depreciation & Amortization | 27.60M |
| Net Borrowing | 40.80M |
| Free Cash Flow | 35.90M |
| FCF Per Share | 3.08 |
Margins
Gross margin is 13.05%, with operating and profit margins of 6.32% and 4.33%.
| Gross Margin | 13.05% |
| Operating Margin | 6.32% |
| Pretax Margin | 6.93% |
| Profit Margin | 4.33% |
| EBITDA Margin | 6.64% |
| EBIT Margin | 6.32% |
| FCF Margin | 0.42% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.14%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.14% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 3.19% |
| Buyback Yield | 19.90% |
| Shareholder Yield | 20.04% |
| Earnings Yield | 4.45% |
| FCF Yield | 0.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 4, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jul 4, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |